Oral Contraceptives and Surgery: When to Stop and Restart
Combined oral contraceptives (COCs) containing estrogen increase the risk of venous thromboembolism (VTE), which is already elevated after surgery. Surgeons routinely ask patients to stop COCs before procedures, but the timeline, alternatives, and restart protocol vary by surgery type. This guide covers the medical reasoning and practical steps.
Combined oral contraceptives (containing ethinyl estradiol) increase the production of clotting factors (Factor VII, Factor X, fibrinogen) and decrease the production of natural anticoagulants (antithrombin III, protein S). This shifts blood chemistry toward clot formation.
Surgery independently increases VTE risk through immobility, tissue damage (which activates the clotting cascade), and venous stasis during and after the procedure. The combination of COC use and surgery creates a compounded risk. The Royal College of Obstetricians and Gynaecologists estimates the VTE risk for COC users undergoing major surgery at 4 to 10 per 1,000, compared to 0.5 to 1 per 1,000 for non-users.
The highest-risk procedures are those involving prolonged immobility: hip and knee replacement, major abdominal surgery, and any procedure requiring more than 30 minutes of general anesthesia with post-operative bed rest. Minor outpatient procedures with immediate ambulation (dental work, skin procedures, endoscopy) generally do not require stopping COCs.
Progestin-only pills (norethindrone, desogestrel), hormonal IUDs (Mirena, Kyleena), and the implant (Nexplanon) do not significantly increase VTE risk and generally do not need to be stopped before surgery. Confirm with your surgeon, but these are considered safe to continue.
When to Stop and What to Use Instead
Most surgical guidelines recommend stopping combined oral contraceptives 4 weeks (28 days) before elective major surgery. This allows clotting factor levels to return to baseline. The British National Formulary, the American College of Chest Physicians, and multiple surgical societies align on this timeline.
If you learn about your surgery less than 4 weeks in advance, tell your surgeon immediately. They may proceed with additional VTE prophylaxis (compression stockings, injectable low-molecular-weight heparin) rather than postponing the surgery. Stopping COCs even 2 weeks before surgery provides partial benefit.
Use a non-hormonal backup contraceptive method during the COC-free period: condoms, a copper IUD, or abstinence. If pregnancy prevention is critical, ask your gynecologist about switching to a progestin-only pill for the 4 weeks before surgery and the recovery period.
The combined contraceptive patch (Xulane) and combined vaginal ring (NuvaRing) carry the same VTE risk as oral combined contraceptives because they contain estrogen. Stop these on the same 4-week timeline. The estrogen clears from the body within 1 to 2 weeks of removal.
Restarting Contraceptives After Surgery
The standard recommendation is to restart combined oral contraceptives no sooner than 2 weeks after surgery, and only once you are fully mobile (walking regularly without assistance). For major orthopedic or abdominal surgery, many surgeons recommend waiting 4 to 6 weeks.
Your surgeon and gynecologist should coordinate the restart timeline. Factors that delay restarting include: ongoing immobility, extended hospitalization, personal or family history of VTE, obesity (BMI over 30), or cancer diagnosis. These patients may need longer COC-free intervals or a permanent switch to progestin-only contraception.
When you restart COCs, you are not immediately protected against pregnancy. It takes 7 consecutive days of pill use to suppress ovulation reliably. Use backup contraception for the first 7 days after restarting.
If you develop leg swelling, calf pain, chest pain, or sudden shortness of breath at any point during the perioperative period (before or after surgery), seek emergency evaluation for VTE. These symptoms require urgent imaging regardless of whether you stopped your COC on schedule.
Do I need to stop birth control pills before dental surgery or a minor procedure?
For minor procedures under local anesthesia (dental extractions, skin biopsies, endoscopy, office procedures) where you will be walking immediately afterward, stopping COCs is generally unnecessary. The VTE risk from these procedures is minimal. However, if your minor procedure requires general anesthesia and more than 30 minutes of immobility, discuss the question with your surgeon.
What happens if I did not stop my birth control before surgery?
If you went into surgery while still on combined oral contraceptives, inform your surgical team. They can provide additional VTE prophylaxis during and after surgery: sequential compression devices on your legs during the procedure, early ambulation, and possibly a short course of injectable low-molecular-weight heparin (enoxaparin). The risk increase is manageable with these interventions.
Does hormone replacement therapy (HRT) carry the same surgical risk as birth control pills?
Oral HRT containing conjugated estrogens or estradiol does increase VTE risk, though the absolute risk is lower than with COCs because HRT estrogen doses are lower. Most surgical guidelines recommend stopping oral HRT 4 weeks before major surgery using the same protocol as COCs. Transdermal HRT (patches, gels) carries lower VTE risk than oral forms because estrogen delivered through the skin bypasses the liver's first-pass effect on clotting factor production.
For patients
Get a personalized care plan.
This guide provides general information. For instructions tailored to your specific procedure, ask your provider about QR Rx care plans.
These medication guides are for educational purposes only and do not replace medical advice. Always follow your healthcare provider's specific medication instructions.
